Korro Bio Has Received Approval From The Australian Bellberry Human Research Ethics Committee And Clearance From The Australian Therapeutic Goods Administration To Initiate A Phase 1/2a Study Of KRRO-110 For Alpha-1 Antitrypsin Deficiency
Korro Bio Has Received Approval From The Australian Bellberry Human Research Ethics Committee And Clearance From The Australian Therapeutic Goods Administration To Initiate A Phase 1/2a Study Of KRRO-110 For Alpha-1 Antitrypsin Deficiency
Korro Bio已获得澳大利亚Bellberry人类研究伦理委员会的批准,以及澳大利亚治疗用品管理局的许可,以启动KRRO-110针对α-1抗胰蛋白酶缺乏症的1/2a期研究。
Korro Bio Has Received Approval From The Australian Bellberry Human Research Ethics Committee And Clearance From The Australian Therapeutic Goods Administration To Initiate A Phase 1/2a Study Of KRRO-110 For Alpha-1 Antitrypsin Deficiency
Korro Bio已获得澳大利亚Bellberry人类研究伦理委员会的批准,并获得澳大利亚治疗货物管理局的清关,启动KRRO-110用于α-1抗胰蛋白酶缺乏症的1/2a期研究